doi: 10.1371/journal.pone.0009280 30 LongoN.FrigeniM.PasqualiM

A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care (2018) Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review, Therapeutic Advances in Chronic Disease (2022) Clinical insight on semaglutide for chronic weight management in adults: Patient selection and special considerations, Drug Design, Development and Therapy (2022) Wegovy, DailyMed (2024) Rybelsus, DailyMed (2024) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) One month weight loss predicts the efficacy of liraglutide in obese patients: Data from a single center, Endocrine Practice (2020) Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes2022 , American Diabetes Association (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

In the body, ipamorelin mimics ghrelin, a hormone that stimulates hunger, helps prevent muscle wasting, and regulates fat storage
According to Bonaca and colleagues, improved blood flow translates to enhanced quality of life, demonstrated by the 2025 results of the STRIDE trial, in which semaglutide significantly increased walking distance and improved function in patients with peripheral arterial disease and type 2 diabetes
It's not inherently dangerous, but it's usually unnecessary and can increase side effects
Could a medication meant to combat diabetes and shrink waistlines also boost fertility